EdgarLookup

Taysha Gene Therapies, Inc. — DEFA14A Filings

4 DEFA14A filings on record

This page lists all DEFA14A filings submitted to the SEC by Taysha Gene Therapies, Inc. (TSHA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Taysha Gene Therapies, Inc. has filed 4 DEFA14A documents with the SEC since 2020. To view all SEC filings by Taysha Gene Therapies, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 144/A 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
DEFA14A DEFA14A 0001193125-25-087216 Apr 21, 2025 —
DEFA14A DEFA14A 0001193125-24-100817 Apr 18, 2024 —
DEFA14A DEFA14A 0001193125-23-138223 May 8, 2023 —
DEFA14A DEFA14A 0001193125-22-127848 Apr 28, 2022 —